DMAAR vs WH · $1.8M cap vs P/E 20, rev $702.0M
Drugs Made In America Acquisition Corp. Rights (DMAAR) versus Wyndham Hotels & Resorts Inc (WH) — a side-by-side from cached financials, not a winner call.
Drugs Made In America Acquisition Corp. Rights (DMAAR) common stock listed on US.
Wyndham Hotels & Resorts Inc (WH) is a lodging company listed on US.
DMAAR does not have a complete income-statement cache yet.
Latest reported WH revenue for 2026-06-30 was $702.0M. Net income was $163.0M. WH currently screens at market cap $6.51B and trailing P/E 20.1.
DMAAR currently screens at market cap $1.8M. WH currently screens at market cap $6.51B and trailing P/E 20.1.
Not investment advice. Open the DMAAR and WH stock pages for the full models.
Not investment advice.